Molecule intelOpportunity: ModerateEssentialCrowded market

Retinol

141 brands · 81 companies · product forms

ATC: D10AD02, R01AX02, S01XA02 1 DRAP alert

Opportunity snapshot

Launch attractiveness
35
Market saturation
98
Price room
100
Regulatory risk
50
141
brands
81
companies
Rs 183.5
median price
26
price points
90.92x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 21.24
MedianRs 183.5
Most expensiveRs 1,931.21
Spread90.92×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 90.92x across 26 trusted points (Rs 21.24-1931.21). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 3 live products for Retinol — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2024-12-03
Rapid Alert: Falsified Dayquil Kids (Vicks) Berry Cold & Cough + Mucus Purportedly Manufac

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(2) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

81 canonical companies and 141 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 90.92x across 26 trusted points (Rs 21.24-1931.21). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2024-12-03 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.